Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2026-01-01 @ 4:42 AM
Study NCT ID:
NCT05233033
Status:
COMPLETED
Last Update Posted:
2024-12-10
First Post:
2022-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL
Sponsor:
Kymera Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-28
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-18
First Submit QC Date:
None
Study First Post Date:
2022-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-05
Last Update Post Date:
2024-12-10
Last Update Post Date Type:
ACTUAL